Complement-Based Drug Development Summit leaderboard
  • Saturday, August 29, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 359

Author

Pharma Journalist 9027 posts 0 comments

Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program (CORAL)…

Aug 17, 2021
Gritstone bio, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding…
Read More...

Nexus Pharmaceuticals Receives Patent for EMERPHED Ready-To-Use Ephedrine Sulfate Injection

Aug 17, 2021
Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED Ready-To-Use Ephedrine…
Read More...

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Aug 17, 2021
Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in…
Read More...

Virpax Pharmaceuticals Receives FDA Response and Guidance on MMS019

Aug 17, 2021
Virpax Pharmaceuticals, Inc. a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has received a written…
Read More...

Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite…

Aug 16, 2021
Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader…
Read More...

Exelixis and Invenra Expand Collaboration to Discover and Develop Novel Biologics in Oncology

Aug 16, 2021
Exelixis, Inc. and Invenra, Inc. announced that they have expanded their discovery and licensing collaboration to include an additional 20 oncology targets. The augmented partnership…
Read More...

InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332

Aug 16, 2021
InnoCare, a leading biopharmaceutical company focusing on drug innovation for cancer and autoimmune diseases, announced the first subject dosed in clinical trial of novel TYK2 (Tyrosine…
Read More...

Wnt & β-Catenin Targeted Drug Discovery Summit – The Only Conference that will Accelerate…

Aug 13, 2021
Over the last 2 decades, scientists and drug developers have been puzzled yet fascinated by Wnt/β-Catenin – its role in maintaining cancer stem cells, regulating numerous gene…
Read More...

Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of…

Aug 12, 2021
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the publication of new data on the durability of the Moderna COVID-19 vaccine…
Read More...

Nimbus Therapeutics and Schrödinger Extend Longstanding Collaboration to Discover Novel Therapeutics…

Aug 12, 2021
Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, announced the extension of its collaboration with…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.